[Cylosporine posological individualization strategies in renal transplant patients].
Porta
B
B
Servicio de Farmacia, Hospital Universitario Dr. Peset, Valencia. porta_beg@gva.es
Pérez Ruixo
J J
JJ
Jiménez Torres
N V
NV
Crespo
J
J
D002986:Clinical Trials as Topic; D016572:Cyclosporine / Q000008:administration & dosage* / Q000009:adverse effects; D016903:Drug Monitoring / Q000379:methods*; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D016030:Kidney Transplantation / Q000379:methods*; D008962:Models, Theoretical
D007166:Immunosuppressive Agents; D016572:Cyclosporine